CCM Duopharma Pays Out Higher Dividend Based on Improved Revenue and Profit Performances For H1 2018
Kuala Lumpur – CCM Duopharma Biotech Berhad (CCM Duopharma) grew its Revenue by 7.03 per cent to RM257.25 million from RM240.36 for the first half of its financial year ended June 30, 2018.